Separately, the US drugmaker said data from a new study showed a combination of two of its antibody treatments helped reduce hospitalization and emergency room visits for COVID-19 patients.
Eli Lilly applies for FDA emergency use of COVID-19 treatment
By MAARIV
04/23/2024 01:55 PM
By REUTERS
04/23/2024 12:13 PM
By REUTERS
04/23/2024 10:10 AM
By REUTERS
04/23/2024 08:46 AM
By MAARIV
04/23/2024 07:15 AM
By REUTERS
04/23/2024 06:15 AM
By REUTERS
04/23/2024 12:08 AM
By REUTERS
04/22/2024 10:40 PM